Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-02-21

Clinical Trial Update: Vonoprazan-based Therapy Versus Standard Regimen for Helicobacter Pylori Infection Management [Phase 4]

View source ↗

Summary

Phase 4 clinical trial comparing vonoprazan-based therapy against a standard regimen for Helicobacter pylori infection has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Vonoprazan (vonoprazan)

Snippet

Sponsor: Alexandria University | Conditions: Helicobacter Pylori Infection | Phase 4 | Status: COMPLETED